Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm
“All my pension I put into Pfizer stock,” Bourla told Barron’s Editor at Large Andy Serwer on Monday, in a recording of At Barron’s on the sidelines of the World Economic Forum. “I’m all in.”
Regulatory filings with the Securities and Exchange Commission show that Bourla conducted an intra-plan transfer in his Supplemental Savings Plan pension for nearly 376,000 Pfizer units of so-called phantom stock in mid-December. The phantom units will be settled in cash at a price of $26.63 each—$10 million altogether—when Bourla leaves the company, and may be transferred by him into an alternative investment account at any time. The company confirmed the transaction was made with holdings from a pension fund of Bourla’s.
It’s a personal bet on Pfizer executing a turnaround—one that Bourla wants to oversee himself, as Wall Street raises questions over the future of his leadership.
"People are best convinced by reasons they discover themselves"